- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Acuson shares rise on rating upgrade
Acuson's long-suffering stock price got a big boost this monthafter an analyst at Morgan Stanley raised his rating of the stockfrom "neutral" to "outperform."The Mountain View, CA, ultrasound vendor's stock leaped 31%the week of Sept.
Acuson's long-suffering stock price got a big boost this monthafter an analyst at Morgan Stanley raised his rating of the stockfrom "neutral" to "outperform."
The Mountain View, CA, ultrasound vendor's stock leaped 31%the week of Sept. 9, from $13.63 on Sept. 8, the day before therating was issued, to $17.88 at the end of the week. It was tradingat around $17.50 last week.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
